Early Diagnosis of Bronchopulmonary Dysplasia with E-Nose: A Pilot Study in Preterm Infants
Open Access
Abstract
Bronchopulmonary dysplasia (BPD) is the most common respiratory disease in preterm and is still associated with increased mortality and morbidity. The great interest lies in identifying early biomarkers that can predict the development of BPD. This pilot study explores the potential of e-nose for the early identification of BPD risk in premature infants by analyzing volatile organic compounds (VOCs) in the exhaled breath condensate (EBC). Fourteen mechanically ventilated very preterm infants were included in this study. The clinical parameters and EBC were collected within the first 24 h of life. The discriminative ability of breath prints between preterms who did and did not develop BPD was investigated using pattern recognition, a machine learning algorithm, and standard statistical methods. We found that e-nose probes can significantly predict the outcome of “no-BPD” vs. “BPD”. Specifically, a subset of probes (S18, S24, S14, and S6) were found to be significantly predictive, with an AUC of 0.87, 0.89, 0.82, 0.8, and p = 0.019, 0.009, 0.043, 0.047, respectively. The e-nose is an easy-to-use, handheld, non-invasive electronic device that quickly samples breath. Our preliminary study has shown that it has the potential for early prediction of BPD in preterms.Keywords
All Related Versions
This publication has 45 references indexed in Scilit:
- Association between individual sensor behavior of an electronic nose and airways inflammation in children with asthma: a pilot study at alpine altitude climatePediatric Pulmonology, 2024
- Recent Advances in Bronchopulmonary DysplasiaIndian Journal of Pediatrics, 2021
- Clinical metabolomics of exhaled breath condensate in chronic respiratory diseases2019
- The economic impact of prematurity and bronchopulmonary dysplasiaEuropean Journal of Pediatrics, 2017
- Electronic Nose Technology in Respiratory DiseasesLung, 2017
- Hospital Variation and Risk Factors for Bronchopulmonary Dysplasia in a Population-Based CohortJAMA Pediatrics, 2015
- Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants2014
- Early biomarkers as predictors for bronchopulmonary dysplasia in preterm infants: a systematic reviewEuropean Journal of Pediatrics, 2013
- Airway angiopoietin‐2 in ventilated very preterm infants: Association with prenatal factors and neonatal outcomePediatric Pulmonology, 2011
- Partial least squares for discriminationJournal of Chemometrics, 2003